Blue Fin Capital, Inc. Bristol Myers Squibb CO Transaction History

Blue Fin Capital, Inc.

$529 Million
Q4 2024

A detailed history of Blue Fin Capital, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 7,274 shares of BMY stock, worth $340,786. This represents 0.08% of its overall portfolio holdings.

Number of Shares

7,274

Previous 7,306 0.44%

Holding current value

$340,786

Previous $378,000 8.73%

% of portfolio

0.08%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 18, 2025	SELL	$51.92 - $59.94 $1,661 - $1,918	-32 Reduced 0.44%	7,274 $411,000
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $27,492 - $31,171	-573 Reduced 7.27%	7,306 $396,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $1,987 - $2,371	-41 Reduced 0.52%	7,879 $404,000
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $6,310 - $7,055	-109 Reduced 1.36%	7,920 $459,000
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $16,361 - $18,557	-249 Reduced 3.01%	8,029 $556,000
Q4 2022 Jan 23, 2023	SELL	$68.48 - $81.09 $1,780 - $2,108	-26 Reduced 0.31%	8,278 $0
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $12,200 - $13,436	-168 Reduced 1.98%	8,304 $639,000
Q1 2022 Apr 12, 2022	SELL	$61.48 - $73.72 $2,213 - $2,653	-36 Reduced 0.42%	8,472 $618,000
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $18,770 - $21,882	-350 Reduced 3.95%	8,508 $530,000
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $17,573 - $20,585	-297 Reduced 3.24%	8,858 $524,000
Q2 2021 Jul 19, 2021	SELL	$61.91 - $67.42 $19,811 - $21,574	-320 Reduced 3.38%	9,155 $611,000
Q1 2021 May 05, 2021	SELL	$59.34 - $66.74 $6,527 - $7,341	-110 Reduced 1.15%	9,475 $598,000
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $12,356 - $14,002	-214 Reduced 2.18%	9,585 $594,000
Q3 2020 Oct 28, 2020	SELL	$57.43 - $63.64 $14,702 - $16,291	-256 Reduced 2.55%	9,799 $590,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $72,636 - $84,919	-1,325 Reduced 11.64%	10,055 $591,000
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $22,875 - $33,242	-493 Reduced 4.15%	11,380 $634,000
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $51,195 - $60,699	-1,197 Reduced 9.16%	11,873 $602,000
Q2 2019 Jul 22, 2019	SELL	$44.62 - $49.34 $10,039 - $11,101	-225 Reduced 1.69%	13,070 $592,000
Q1 2019 Apr 23, 2019	SELL	$45.12 - $53.8 $3,790 - $4,519	-84 Reduced 0.63%	13,295 $634,000
Q4 2018 Jan 16, 2019	SELL	$48.76 - $63.23 $64,899 - $84,159	-1,331 Reduced 9.05%	13,379 $695,000
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $81,405 - $91,818	-1,475 Reduced 9.11%	14,710 $913,000
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $67,710 - $84,393	-1,340 Reduced 7.65%	16,185 $896,000
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $22,769 - $26,212	380 Added 2.22%	17,525 $1.11 Million
Q4 2017 Jan 26, 2018	SELL	$59.94 - $65.35 $13,786 - $15,030	-230 Reduced 1.32%	17,145 $1.05 Million
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $959,621 - $1.11 Million	17,375	17,375 $1.11 Million

Others Institutions Holding BMY

# of Institutions

2,806

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.6B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Fin Capital, Inc. with notifications on news.

Account

Blue Fin Capital, Inc. Bristol Myers Squibb CO Transaction History